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Abstract
A novel intrinsic HIV-1 antisense gene was previously described with RNA initiating from the
region of an HIV-1 antisense initiator promoter element (HIVaINR). The antisense RNA is exactly
complementary to HIV-1 sense RNA and capable of forming ~400 base-pair (bp) duplex RNA in
the region of the long terminal repeat (LTR) spanning the beginning portion of TAR in the repeat
(R) region and extending through the U3 region. Duplex or double-stranded RNA of several
hundred nucleotides in length is a key initiating element of RNA interference (RNAi) in several
species. This HIVaINR antisense RNA is also capable of forming multiple stem-loop or hairpin-like
secondary structures by M-fold analysis, with at least one that perfectly fits the criteria for a
microRNA (miRNA) precursor. MicroRNAs (miRNAs) interact in a sequence-specific manner with
target messenger RNAs (mRNAs) to induce either cleavage of the message or impede translation.
Human mRNA targets of the predicted HIVaINR antisense RNA (HAA) microRNAs include
mRNA for the human interleukin-2 receptor gamma chain (IL-2RG), also called the common
gamma (γc) receptor chain, because it is an integral part of 6 receptors mediating interleukin
signalling (IL-2R, IL-4R, IL-7R, IL-9R, IL-15R and IL-21R). Other potential human mRNA targets
include interleukin-15 (IL-15) mRNA, the fragile × mental retardation protein (FMRP) mRNA, and
the IL-1 receptor-associated kinase 1 (IRAK1) mRNA, amongst others. Thus the proposed intrinsic
HIVaINR antisense RNA microRNAs (HAAmiRNAs) of the human immunodeficiency virus form
complementary targets with mRNAs of a key human gene in adaptive immunity, the IL-2Rγc, in
which genetic defects are known to cause an X-linked severe combined immunodeficiency
syndrome (X-SCID), as well as mRNAs of genes important in innate immunity. A new model of
intrinsic RNA silencing induced by the HIVaINR antisense RNA in the absence of Tat is proposed,
with elements suggestive of both small interfering RNA (siRNA) and miRNA.
Background
In life, timing is everything. Developmental transitions
must be exquisitely and appropriately timed, for an ani-
mal to develop normally. Genes have to know when to
turn on and when to turn off. Proteins need to be trans-
lated efficiently when (and where) they will do the most
good. Two early examples of a unique form of regulation
of gene expression by RNA instead of the more usual pro-
tein were mediated by the 22-nucleotide lin-4 RNA[1,2]
and the 21-nucleotide (nt) let-7  RNA [3]. These small
RNAs were found to regulate the timing of development
in the roundworm, the nematode Caenorhabditis elegans
[1,4,5]. The lin-4 22 nt and 61 nt precursor were noted to
have antisense complementarity to several sites in the lin-
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14 gene, in sites already known to be important in medi-
ating repression of lin-14 [1,2]. Each final, small RNA is
processed from larger RNAs and is very specific in its
action because it is complementary to sequences in the 3'
untranslated regions (3'UTR) of a specific set of mRNAs of
protein-coding target genes [1-3,5,6]. Remarkably, the 21
nt RNA encoded by the let-7 gene appears to be conserved
across species, from the original roundworms and mol-
luscs to drosophila and to vertebrates, including humans
[4]. Recently, these tiny RNAs or microRNAs (miRNAs)
have been shown to regulate a wide range of biological
processes besides developmental timing, including apop-
tosis, differentiation, hormone secretion, and even cancer
(reviewed in [7-11]. It has also been proposed that small
RNAs may play important roles in the host-pathogen
interaction: both by mammalian cells to defend against
viral infections, and by some viruses, in turn, to escape or
adapt to RNA silencing [12].
In the human immunodeficiency virus (HIV-1), the virus
has already "borrowed" known transcription factor bind-
ing sites and enhancer elements (NFAT, NFkB, Tata box,
Sp1 sites) to enable it to effectively utilize the human host
cell proteins and RNA polymerase in transcription of its
mRNAs and genomic RNA[13]. It is perhaps not surpris-
ing that it would also make an antisense RNA to enable a
mechanism for fine-tuning the timing of final transla-
tional expression of its genes [14]. It would be extremely
inefficient to make proteins required for the complete vir-
ion if conditions in the cell are suboptimal. In the absence
of Tat protein, one of the early regulatory proteins made
by the virus, short transcripts of approximately 55–60 nt
are predominantly observed [15]. Some early experiments
even suggested negative regulatory elements or an inducer
of short transcripts to maintain the virus in latency, as
when the human host cell was not activated [16]. More
recent papers have suggested that the trans-activation-
response region (TAR) of HIV-1 mRNA, present in all
sense HIV-1 transcripts, functions as a microRNA precur-
sor [17,18].
This paper explores the possibility that HIV-1 might incor-
porate two mechanisms for RNA silencing that contribute
to maintenance of a quiescent state in the host cell, in the
absence of Tat protein. It was previously shown that the
antisense RNA originating from the region of the HIV
antisense initiator (HIVaINR) promoter element is pro-
duced simultaneously along with the sense transcripts
[14]. This HIVaINR antisense RNA forms an intrinsic
bimolecular duplex with U3R sense mRNA (at the 3' end
of HIV genomic RNA or mRNA) and suggests the capacity
for RNA interference (RNAi). The RNAi pathway begins
with long double-stranded RNA, which are naturally gen-
erated within the host cell from both HIV-1 sense and
antisense transcripts [14]. HIVaINR antisense RNA begins
off a site in the R region and extends through the U3
region with perfect complementarity but opposite polar-
ity to its template sense DNA U3R strand. It would there-
fore have perfect complementarity to any sense HIV
mRNA consisting of 3' U3R sequence. It also would have
perfect complementarity to the beginning region of all
HIV-1 sense mRNAs at the 5'R or TAR region, forming a 25
bp duplex as previously described [14]. In the RNAi path-
way, double-stranded RNA is processed by Dicer and then
unwound into many ≈22 nt small interfering RNAs (siR-
NAs), with one strand of the duplex small RNA incorpo-
rated into a ribonucleoprotein complex called the RNA-
induced silencing complex (RISC) [19-22]. Complemen-
tary base-pairing between the siRNA incorporated into the
RISC and the mRNA determines the targeted mRNA sites,
with cleavage of the mRNA directed between the nucle-
otides pairing to residues 10 and 11 of the siRNA [23,24].
In HIV-1, the siRNAs would be capable of targeting multi-
ple intrinsic sites on HIV mRNAs because of the extensive
perfect complementarity of an intrinsically produced HIV-
aINR antisense RNA. The converse may also be true, inas-
much as the sense strand of the siRNA duplex could also
be targeting the HIVaINR antisense RNA.
However, the HIVaINR antisense RNA itself also has
extensive secondary structure and is capable of forming
intramolecular duplex structures or extended hairpins
(discussed below). Some of these intrinsic HIVaINR anti-
sense RNA hairpins fit criteria for a microRNA precursor.
Thus, a second mechanism employed by the virus for gene
silencing may involve the microRNA (miRNA) pathway
utilizing this HIVaINR antisense RNA, which will be
explored below. Because of the human gene mRNAs also
potentially targeted, this may represent intrinsic mecha-
nisms for (self) viral and human host gene regulation by
the HIV-1 virus. In the process, the HIV-1 targeting of spe-
cific human genes may have profound effects on the
human host adaptive and innate immunity.
Results and Discussion
Could the HIVaINR antisense gene encode its own 
microRNA subspecies?
The capacity for an intrinsic RNA regulatory mechanism
for control of HIV-1 gene expression by means of an anti-
sense RNA initiated from the HIVaINR in TAR (LTR) DNA
has been suggested previously [14]. This antisense RNA
most notably has the capacity to form a duplex of 25 bp
with the 5' end of all sense HIV mRNA and genomic HIV-
1 RNA (see additional file 3 (figure 3S) in [14]). At the
time this was initially proposed in 1996, the known mod-
els for duplex RNAs regulating genes were in prokaryotes
[25,26]; the term "microRNA" would not be coined until
2001 [6,27,28]. However, this same HIVaINR antisense
RNA which encodes antisense proteins (HAPs), also has
the capacity to form hairpin structures that could be pre-Retrovirology 2008, 5:79 http://www.retrovirology.com/content/5/1/79
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cursors to the formation of intrinsic viral microRNAs
(vmiRNAs) named the HIVaINR antisense RNA miRNAs
or HAAmiRNAs [14]. Others have suggested the possibil-
ity for HIV microRNAs encoded by the sense strand of HIV
mRNAs with the potential for an entirely different set of
human cellular target mRNAs[17,18,29,30].
HIVaINR antisense RNA forms extensive intrinsic duplex
structure by M-fold analysis and DINAMelt server (see Fig-
ure 1 and additional file 1). Nineteen separate HIVaINR
antisense RNA duplex structures with dG of -99.2 to -94.9
could form by the enhanced Mfold program (additional
file 1) [31-33]. The plasticity of structure demonstrated is
remarkable, but still does not represent all the potential
influences on 3-dimensional RNA structure; the effect of
protein binding or pseudoknot formation is not consid-
ered. miRNAs are generated from long primary transcripts
containing hairpin or stem-loop structures (pri-miRNAs)
that are first processed in the nucleus by the RNase III
enzyme Drosha in partnership with the dsRNA binding
protein, DGCR8 or DiGeorge syndrome critical region
gene 8 [34-36]. The prototypic metazoan pri-miRNA con-
sists of a stem of ~32–33 base-pairs (bp) with a terminal
loop and flanking single-stranded RNA at the base of the
stem-loop, although in plants, the stem-loop might be
much longer [7,37]. Cleavage by the Drosha-DGCR8
Secondary structure of HIVaINR antisense RNA[14] predicted by enhanced Mfold [31-33] Figure 1
Secondary structure of HIVaINR antisense RNA[14] predicted by enhanced Mfold [31-33]. This is one of 19 struc-
tures predicted, but was chosen to illustrate the extensive duplex structure of the HIVaINR antisense RNA[14], with the pre-
dicted microRNA sites 1, 2, and 3 indicated. HAAmiRNA site 1 has complementary sequence to multiple sites in mRNA of the 
interleukin-2 receptor (IL-2R) gamma chain, also called the common γ chain, and to sites in the mRNA of interleukin-15 (IL-
15). HAAmiRNA site 2 has complementary sequence to fragile-X mental retardation protein (FMR1) mRNA. HAAmiRNA site 
3 has complementary sequence to sites in the interleukin-1 (IL-1) receptor-associated kinase 1 (IRAK1) mRNA. Discussed in 
text.
IL2Rgamma (C)
IL-15         1. FMR1
    2.
IRAK1  
    3.
Predicted HAAmiRNA sites 1, 2, and 3 from
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complex converts the pri-miRNA into small stem-loop
structures called precursor miRNAs (pre-miRNAs). This is
then further processed by another RNase III enzyme
(Dicer)/dsRNA binding protein duo into mature miRNAs.
In an elegant paper by Ritchie, et al., they addressed what
parameters might distinguish precursor miRNAs (pre-
miRNAs) from other duplex structures of similar size and
free energy [38]. In a cellular world in which long RNA
duplexes are frequent, the RNAse III enzymes of the
microRNA pathways, Drosha and Dicer, must be able to
distinguish the appropriate RNA stem-loops that signal a
primary or precursor miRNA for cleaving into the mature
21- to 25- nucleotide (nt) long, single-stranded miRNA
[38,39]. Some reports suggest that a larger apical loop
size, as well as flanking single-stranded RNA extensions at
the base of the primary miRNA hairpin is important for
Drosha function[40,41]. A recent study found the termi-
nal loop was not essential, but the cleavage site for Drosha
was determined by the distance (~11 bp) from the base of
the hairpin stem and single-stranded RNA junction [37].
While folding free energy and stem length were not suffi-
cient to discrimate miRNA precursors from other long
RNA duplexes, it was determined by computational anal-
ysis that nonprecursor duplexes differed from real miRNA
precursors in having increased lengths and numbers of
bulges and internal loops and larger apical loop size [38].
These secondary structure characteristics were utilized in
developing a miRNA prediction algorithm, with compari-
sons done using the RNAforester tool [42,43]. When the
HIVaINR antisense RNA sequence from nt 168–253 [14]
was submitted to this structure-based miRNA analysis
tool for analysis, it received a perfect score (100) consist-
ent with this sequence being a microRNA precursor
(Ritchie et al, http://tagc.univ-mrs.fr/mirna/) [38]. Further
comparison with the M-fold duplexes demonstrated that
even with the 390 nucleotide HIVaINR antisense RNA
[14] subjected to enhanced M-fold, some of the structures
could potentially be processed (first by Drosha, then
Dicer) into this final pre-miRNA (see additional file 1,
structure with folding energy dG = -96.7). This was impor-
tant, inasmuch as the HIVaINR antisense RNA stem-loop
also contained 25 bases that could in turn form yet
another duplex or target with several human mRNAs. Two
of the many mRNAs targeted included mRNA of the
human gene, interleukin-2 receptor gamma chain (IL-
2Rγc), a gene in which defects are responsible for X-linked
severe combined immuno-deficiency (X-SCID), as well as
the human interleukin-15 mRNA, discussed below (dia-
grammed in Figure 2A, B, E).
Human interleukin-15 mRNA: a proposed target of the 
HIVaINR antisense RNA site 1 (HAAmiRNA 1, *1)
HIVaINR antisense RNA sequence from nt 168–253 [14]
is capable of forming a stem-loop or hairpin structure
consistent with a precursor miRNA (Figure 1 and addi-
tional file 1) [31,33,38]. The hairpin structure or pre-
miRNA thus could be processed by Dicer to yield two
strands of short RNA. Each strand appears capable of
interacting with a number of human target mRNAs using
BLASTN of the NCBI (Figure 1, Figure 2, and data not
shown). In microRNAs, a core element or "seed" region of
~7 or 8 nucleotides (nt) at the 5' region of the microRNA
is particularly required for microRNA complementary
base-pairing to the messenger RNA (mRNA) target
sequences[44]. Residues 2–8 of the microRNA have been
proposed to represent the core region initially presented
by the RNA-induced silencing complex or RISC for nucle-
ate pairing to the mRNAs (reviewed in [7,39]). If sufficient
additional base-pairing between the microRNA and
mRNA occurs, cleavage of the message (mRNA) can occur
[7]. However, the core "seed" pairing, supplemented by
just a few flanking base-pairing residues appears sufficient
to mediate translational repression[7,45].
Figure 2B illustrates some of the interactions possible
between the HAAmiRNA site 1 strands and human mRNA
for interleukin-15 (IL-15). HAAmiRNA site 1 from nucle-
otides 225–246[14] can form a complementary base-
paired structure with human IL-15 mRNA at multiple
sites. Interleukin-15 mRNA nucleotides 1143–1171 and
HAAmiRNA 1 form a duplex with 19 base-paired ele-
ments, including a 7 base-pair "seed" (Figure 2B). IL-15
mRNA from nucleotides 857–878 and HAAmiRNA 1
form a duplex with 14 base-pairs, including a 10 base-pair
"seed" (Figure 2B, underlined). The opposing strand of
the precursor miRNA (HAAmiRNA 1*) might also target
human IL-15 mRNA (Figure 2B, yellow star). HAAmiRNA
1* from nucleotides 175–204 [14] forms a 18 base-pair
duplex with human IL-15 mRNA nucleotides 682–708,
including a 10 base-pair "seed" (Figure 2B, yellow star). It
is not unusual that a functional microRNA will target mul-
tiple sites in a mRNA [44,46,47]. It is interesting that sev-
eral of these target sites are in the IL-15 mRNA coding
region, which is expected in plants, but has typically not
been looked for in mammals, where the focus has been on
detecting target sites in the 3'UTR [48]. However, it has
been reported that short RNAs partially complementary to
a single site in the coding sequence of mRNA targets of
endogenous human genes can mediate translational
repression [49]. Given viral versatility and adaptability, it
would be premature to assume that only the 3'UTR of
mRNAs could be the target for vmiRNAs.
Interleukin-15 is a cytokine that is important in regulation
of T-cell maturation and natural killer (NK) cell develop-
ment and that is secreted by human macrophages and
other cells [50-54]. Interleukin-15 and interleukin-7 are
required for survival of long-lived memory T cells [50,55].
Studies in mice and humans suggest that a functional IL-Retrovirology 2008, 5:79 http://www.retrovirology.com/content/5/1/79
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Proposed HAAmiRNA human target genes Figure 2
Proposed HAAmiRNA human target genes. (A) Complementary base-pairing between the HIVaINR antisense RNA site 
1 (HAAmiRNA1) from nucleotides (nt) ~225–250 [14] and mRNA sequence encoding the interleukin-2 receptor gamma chain 
(IL-2RG or γC) from nt 6161–6198 in the 3' UTR (upper) and from nt 3103–3133 in an intronic region (lower). The human IL-
2RG sequence was obtained from the NCBI GenBank AY692262. (B) Both strands of HAAmiRNA 1,1* target complementary 
sites in human interleukin-15 (IL-15) mRNA. HAAmiRNA 1 nt 225–250 [14] target IL-15 nt 1146–1166 and IL-15 nt 857–878, 
underlined (upper). The opposite strand HAAmiRNA 1* (yellow star) also targets sites in IL-15 mRNA, as indicated. IL-15 
sequence is GenBank NM172174 transcript variant 1. Purple dots indicate proposed siRNA sequence. (C) HAAmiRNA site 2 
from nt 271–297 [14] complementary base-pairing to human fragile × mental retardation protein mRNA (HsFMR1) is com-
pared with the interaction between HsFMR1 and human miRNA-194 [48]. (D) HAAmiRNA site 3 from nt 341–369 [14] com-
plementary base-pairing to human interleukin-1 (IL-1) receptor-associated kinase 1 (IRAK1) mRNA at site 2 is compared to 
human miRNA-146a [77]. (E) The Mfold structure formed between HAAmiRNA1 and IL-2RG mRNA [31-33].
E.  HAAmiRNA 1:IL-2Rgamma (common   chain)
IL-2Rg
HAAmiRNA 1Retrovirology 2008, 5:79 http://www.retrovirology.com/content/5/1/79
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15/IL-15 receptor signalling pathway is required for devel-
opment and survival of NK cells [50-52,54]. NK cells are a
class of lymphoid cells that contribute to innate host
defense against intracellular pathogens and viruses, as
well as tumor cells[54]. The IL-15 receptor consists of a
unique IL-15Rα chain that combines with two other
receptor chains that are also shared with the IL-2 receptor,
the β and γc subunits. HAAmiRNA 1 also potentially tar-
gets the γc subunit or IL-2Rgamma chain mRNA (dis-
cussed below). The combined effects of HIV-1 microRNA
action to inhibit protein production from these mRNAs
would be predicted to impact on natural killer cell func-
tion. Because NK cell activity represents one of the early
host innate immune responses against virally infected
cells, HIV-1 could thereby strike an early and crippling
blow against the human immune response.
Interleukin-2 receptor gamma chain (common gamma 
chain) (γC)- a proposed human mRNA target of the 
HIVaINR antisense RNA site 1 (HAAmiRNA 1, 1*)
The HIVaINR antisense RNA stem-loop precursor
(HAAmiRNA 1,1*) also contains sequence that can form
duplex structures with several sites on mRNA encoding
the interleukin-2 receptor gamma chain (IL-2RG). IL-2RG
is now known as the common gamma (γc) cytokine recep-
tor chain because it is a component of the interleukin
receptors IL-2R, IL- 4R, IL-7R, IL-9R, IL- 15R, and IL-21R
[56-59]. Genetic defects or mutations in IL-2RG (γc) gene
can cause X-linked severe combined immunodeficiency
(X-SCID) secondary to the profound T cell and NK cell
deficiency induced by lack of a functional γc gene [60-62]
X-linked SCID is so severe that some children who inherit
it can only survive following bone marrow transplanta-
tion or in a pathogen-free environment, as demonstrated
by the Houston child, the "boy in the bubble".
HAAmiRNA 1 from nt 225–250[14] is involved in exten-
sive complementary base-pairing to several sites in the 3'
UTR of IL-2RG mRNA as well as to sites in intronic and 5'
regions of the IL-2RG mRNA (Figure 2A, and data not
shown). HAAmiRNA 1 interaction with the 3'UTR of IL-
2RG mRNA is illustrated in Figure 2A and Figure 2E. A crit-
ical 5' seed of 10 nt are base-paired, followed by a bulge at
nt 11, followed by 11 more interrupted sites of base-pair-
ing such that 22/25 nt of the HAAmiRNA 1 is base-paired
to the target site (Figure 2A, 2E). HAAmiRNA 1 targets a
complementary site in an intron of IL-2RG, with 21 out of
26 nt potentially base-paired with the intronic site (Figure
2A, lower). Interestingly, if Dicer cuts the intermolecular
duplex formed by both HIV-1 sense RNA and HIVaINR
antisense RNA, one of the predicted ~22 nt cleaved frag-
ments (siRNAs) would contain the overlapping sequence
from nt 221–242 [14] (indicated by purple dots in Figure
2A, 2B).
If the human immunodeficiency virus wanted to turn off T-
cell proliferation to enable it to subvert the cell's 
machinery for other purposes, IL-2RG chain (γc) would be 
the perfect switch
The adaptive immune response requires appropriate co-
signals and cytokine stimulation for the T cell to prolifer-
ate in response to recognition of a specific antigen. This is
one of the defining aspects of adaptive immunity: the
capacity to greatly expand the population of T-cells (or B
cells) that specifically recognize a foreign antigen and
thereby bring an infection under control. Central to this
pathway activating lymphocyte proliferation and, para-
doxically, lymphocyte death is an autocrine (and para-
crine) loop involving interleukin-2 and the tripartite
interleukin-2 receptor complex, IL2-R[63]. The inter-
leukin-2 receptor (IL2-R) and IL-15 R are heterotrimers
that consist of a unique α-chain but share the IL-2R
gamma (γ common or γc) chain and IL-2Rβ chain
[59,63,64]. The receptors for the interleukins IL-4, IL-7,
IL-9, and IL-21 are heterodimers with unique α-subunits
and the shared subunit, IL-2RG or γc chain [56-58,64]. For
all of these cytokine receptors, the γc chain contributes to
ligand binding as well as signal transduction within the
cell [54,64-66].
Targeting the human lymphoid cell IL-2Rgamma chain or
γc mRNA by HAAmiRNA 1 could lead to multiple changes
within the cell: impaired production of this receptor chain
protein could alter or eliminate the human CD4+ T cells
ability to proliferate and mount an effective adaptive
immune response and also impair NK cell functioning via
the IL-15R and IL-21R with an impact on innate immu-
nity[56]. NK function also could be impacted by the
absence of a critical cytokine, IL-15, discussed above.
Mutation or gene deletion of the IL-2Rgamma chain (γc)
in humans causes extremely low numbers of T cells, poor
or absent T cell mitogen responses, severely depressed NK
cell function, and an elevated or normal proportion of B
cells that fail to produce specific antibodies[62]. Each of
these defects are observable in the immune system of HIV-
infected individuals, even before significant depletion of
CD4+ T cells[67]. Even a single missense mutation in the
γc chain can lead to a progressive T cell deficiency [68]. By
analogy, one might expect the gradual accrual over time of
a similar phenotype, as more human cells are infected by
the virus and then incapacitated by viral microRNA trans-
lational inhibition (or cleavage) of the γc mRNA.
Other HIVaINR antisense RNA predicted miRNAs?
A variety of strategies were used to identify potential
miRNA sites within the HIVaINR antisense RNA sequence
[14]. First, the identification of potential microRNA pre-
cursor sites on the HIV-1 sense RNA strand immediately
suggested similar structures were possible on the corre-
sponding complementary antisense RNA that overlappedRetrovirology 2008, 5:79 http://www.retrovirology.com/content/5/1/79
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these regions [29,30] (diagrammed in additional file 2).
This provided the impetus to look at sites encompassing
HAAmiRNAs 1 and 3 (Figure 2A, 2B, and 2D). Second, the
miRNA prediction algorithm, described by Ritchie et al
http://tagc.univ-mrs.fr/mirna/) [38] was also utililized to
analyze overlapping sets of the HIVaINR antisense RNA
sequence. Third, because the entire 390 nt sequence [14]
was also analyzed by enhanced M-fold [31-33], visual
inspection of the RNA duplexes formed was possible, with
extrapolation of potential cleavage sites by Drosha and
Dicer. For instance, if Drosha-DGCR8 complex requires a
minimum of 33 bp stem structure in conjunction with
unpaired or single-stranded RNA at the base of the stem
[37], then a single very extensive hairpin in the structure
labeled dG = -96.7 HAAmiRNA, additional file 1, provides
a substrate that could be cleaved to release potentially
both HAAmiRNAs 1 and 2. The M-fold analysis of the
much longer sequence also provided insight into poten-
tial cleavage sites that would not be detected using analy-
sis simply of contiguous 80–100 nucleotide sequences.
Fourth, a vmiRNA of interest might have complementary
human mRNA targets (as illustrated with HAAmiRNA 1,
1*).
HIVaINR antisense RNA at site 2 between nucleotides
271–297 could potentially target mRNA sequence for
human fragile × mental retardation protein (FMRP) (Fig-
ure 1, Figure 2C). Key aspects of miRNA and target mRNA
matches are: 1) the 5'end of the miRNA tends to have
more bases complementary than the 3' end (with a seed 7
nt base paired in many cases); 2) loopouts in either
mRNA or miRNA between miRNA nt 9 and 14 are often
observed; 3) G:U wobble base-pairs are less common in
the 5' end of the miRNA:mRNA duplex (reviewed
in[44,48]). HAAmiRNA 2 interaction with the human
mRNA for FMRP meets these criteria (Figure 2C, compare
complementary base-pairing between HIVaINR antisense
RNA nt 271–297 and HsFMR1)). It is interesting that
human microRNA 194 (Hs miR-194) also targets this site
in human FMRP mRNA (Figure 2C).
This could be of major impact, if verified experimentally,
because not only does the FMRP play a role in protein syn-
thesis and bind large numbers of cellular mRNAs through
G-quartet and U-rich motifs [69-72], but experimental
evidence links FMRP with RISC components and miRNAs
[73-75]. Mammalian FMRP interacts with miRNAs and
Dicer and the mammalian orthologues of Argonaute
(AGO) 1 [73,75]. Whether HAAmiRNA 2 targeting
human mRNA for FMRP results in translational repres-
sion or cleavage of the human mRNA for FMRP, the effects
will be amplified because of the large number of human
mRNAs targeted by the FMRP protein itself. This would
enable the virus to immediately impact on many hun-
dreds of cellular messages. In addition, the primary RNAs
for human microRNAs may be impacted, as has already
been suggested for HIV-1-transfected human cells [30].
HIV potentially could thus use HAAmiRNA 2 to regulate
the host effort to demolish the virus through host miRNA/
siRNA silencing pathways. If HAAmiRNA 2 impedes effi-
cient translation of FMRP, it also will affect FMRP interac-
tion with proteins of the RNA-induced silencing complex.
Others have already shown the importance of the two
RNAase III enzymes fundamental to RNA silencing, Dro-
sha and Dicer, in inhibiting HIV replication[76].
HIVaINR antisense RNA site 3 from nt 341–369 [14]
(herein referred to as HAAmiRNA 3) could potentially tar-
get human mRNA for the interleukin-1 receptor-associ-
ated kinase 1 (IRAK1) (Figure 1 and 2D[77]. It targets
IRAK1 mRNA via an overlapping site when compared to
IRAK1 interaction with the human microRNA, miR-146a
(Figure 2D) [77]. Many miRNAs are postulated to act
cooperatively for translational repression, requiring two
or more target sites per message [48,78]. However, multi-
ple, diverse miRNAs may impinge on multiple target sites
within a mRNA, leading to effects of multiplicity or coop-
erativity that fine-tune translational repression [78].
HAAmiRNA 3 forms a reasonable "seed" structure of 7
complementary base-pairing nucleotides at the 5'end, fol-
lowed by 12 more complementary base-pairing nucle-
otides that can encompass the human mRNA IRAK1 site 2
(Figure 2D). This can be compared to human miR-146a,
which forms a complementary base-pairing "seed" site
utilizing 8 nucleotides at the 5' end of the miRNA, fol-
lowed by a gap of 5 nucleotides, then 7 nucleotides that
base-pair to the human IRAK1 mRNA site 2 [77] (Figure
2D).
It is of particular interest that human miR-146 has been
shown to functionally interact with human mRNA 3'UTR
sites for IRAK1 and thereby downregulate protein expres-
sion[77]. Expression of primary miR-146 transcripts is
regulated by NF-kB sites, sites that are also important
enhancer elements for expression of HIV-1 RNA tran-
scripts [14,77,79]. IRAK1 is involved in the signalling cas-
cade induced by activation of Toll-like receptors (TLRs)
that are important in innate immunity. Experimental evi-
dence that miR-146a/b may function as a novel negative
regulator has been recently shown [77]. If HIV uses a
microRNA mechanism like miR-146a to interact with
IRAK1 mRNAs, which are expressed in macrophages and
dendritic cells, it may provide yet another means for early
viral impact on the host innate immunity pathways.
RNA silencing by HIVaINR antisense RNA-a proposed 
model (Figure 3)
While RNA silencing triggered by double-stranded RNA
[dsRNA] precursors occurs in a wide variety of eukaryotic
organisms as a mechanism to regulate gene expres-Retrovirology 2008, 5:79 http://www.retrovirology.com/content/5/1/79
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sion[22], early experiments in plants also suggested RNA
silencing is employed as an antiviral mechanism to pro-
tect from RNA viruses [80-83]. To survive, viruses have
had to evolve mechanisms to suppress or avoid the host
RNA silencing response [83,84].
In this model, I propose that HIV-1 employs limited
genetic space to best effect by producing a primary HIV-
aINR antisense RNA with multiple functions (Figure 3a–
d)[14]. The HIVaINR antisense RNA encodes a set of pro-
teins called HIV antisense proteins (HAPs) [14]. The same
HIVaINR antisense RNA enables intrinsic viral RNA
silencing employing short interfering RNAs (siRNAs) and
microRNAs (miRNAs) (Figure 3b and 3c). HIV-1 demon-
strates versatility because the endogenous HIVaINR anti-
sense RNA transcript originating from the HIV antisense
initiator site (HIVaINR) in the long terminal repeat (LTR)
of the provirus has the intrinsic capability of being
employed in either silencing pathway (Figure 3b and 3c).
Because this HIVaINR antisense transcript is produced off
of template U3R sequences of the HIV DNA (sense)
strand, it is exactly complementary in sequence to the
sense HIV mRNA (or HIV genomic RNA) in the U3
(untranslated 3') R (repeat) regions. Thus, hybridization
of overlapping transcripts from sense HIV mRNAs (at the
U3R 3' end) and the HIVaINR antisense RNA produced
from either LTR can form a perfect duplex or double-
stranded RNA of 400–450 bp (Figure 3b). This can func-
tion as an initiating substrate for the RNA interference
(RNAi) pathway and the production of multiple siRNA
duplexes by Dicer (Figure 3b). Once each siRNA duplex is
unwound and a single 21–22 nucleotide (nt) strand is
incorporated into the RNA-induced silencing complex
(RISC), it can potentially guide mRNA degradation (Fig-
ure 3b) or chromatin modification (Figure 3a). The siRNA
interacts in a sequence-specific manner with the corre-
sponding complementary sequences in (sense) HIV
mRNA found at the beginning TAR region (5') as well as
in multiple sites at the end of all sense mRNA transcripts
containing U3R (3') (diagrammed in Figure 3b), as previ-
ously described [14,85]. By cleavage of the corresponding
sense mRNAs at the many sites available in the exactly
complementary regions spanning the U3R-3', and the
beginning portion of the TAR mRNA at the 5'end of HIV
sense messages, these HIVaINR antisense RNA-generated
siRNAs could profoundly impact HIV gene expression.
The endogenous HIVaINR antisense RNA further has the
intrinsic capacity for forming multiple dsRNA hairpin
structures with complementary or near-complementary
base-pairing (Figure 1 and additional file 1). Primary HIV-
aINR antisense RNA has the potential to form precursor-
like microRNAs and HAAmiRNAs, as discussed above
(Figure 3c). In mammals, maturation of miRNAs is initi-
ated by nuclear cleavage of longer primary miRNA tran-
scripts by the Drosha RNAse III endonuclease to liberate
stem-loop precursors referred to as precursor miRNAs
(pre-miRNAs) (Figure 3c)[34,86]. Drosha exists in a com-
plex with a dsRNA-binding protein called DGCR8 [35-
37]. This initial cut by Drosha yields a stem-loop with a
5'phosphate and 2 nt 3' overhang at the base [34,87]. Pre-
miRNA is then transported out of the nucleus by Ran-GTP
and Exportin-5 [88-90], where it would be cleaved by the
RNase III enzyme Dicer to form the HAAmiRNA/miRNA*
duplex (Figure 3c) [34,91]. Dicer is believed to use a sim-
ilar mechanism to that proposed for bacterial RNase III to
generate ≈22 miRNA duplexes [92]. Dicer functions in
both the miRNA maturation pathway and the siRNA gen-
eration pathway (Figure 3b and 3c), reviewed in [7,93].
Recently Dicer was shown to operate along with the TRBP
or transactivating response RNA binding protein [94-96].
Like the siRNA duplex, the miRNA:miRNA* duplex is
unwound, and one miRNA strand is preferentially associ-
ated with a ribonucleoprotein complex (miRNP) contain-
ing the proteins eIF2C2, and helicases Gemin3 and
Gemin4 [85,97,98]. The miRNA within the ribonucleo-
protein complex serves to guide the protein machinery to
complementary sites in the human cell messenger RNAs
(mRNAs), where either translational repression or mes-
sage cleavage occurs[7,22,78]. It is also possible that the
intrinsic HAAmiRNAs might target corresponding targets
in the viral mRNA (Figure 3c, dotted arrow). The human
Argonaute homolog eIF2C2 is a component of the human
siRNA-RNA-induced silencing complex (RISC) [85].
Therefore, the RISC/miRNP components may be similar,
if not indistinguishable (Figure 3b, 3c). The "minimal"
active RISC may contain only Argonaute (Ago) proteins
associated with siRNAs, indicating that the Ago compo-
nent catalyzes mRNA cleavage[85,99]. In mammals, only
Ago2 is able to support mRNA cleavage upon incorpora-
tion in the RISC [99-101]. Mutagenesis of recombinant
human Ago2 showed that a DDH rather than a DDE triad
of amino acids played a critical role in catalysis [101]. In
addition to the guide siRNA/miRNA and Ago, the core cat-
alytic component of the RISC [75], additional proteins
that have been (variably) associated with the RISC include
the Vasa intronic gene protein (VIG), Fragile X-related
protein (drosophila) or the human fragile × mental retar-
dation protein (FMRP), and Tudor-SN [22,73-75,102].
Why would a virus utilize host cell enzymes Drosha and
Dicer to dice up its own messages? Here, we must return
to the initial concept of this paper, where timing of gene
expression is so important to viral survival. The early skir-
mish in the battle between the virus and the host cell
might require some sacrifice of intact viral messages for a
time. By generating HAA miRNAs that incorporate into
the host cell RISC, the virus can impede mRNAs from the
host genes critical in enabling host innate as well as adap-
tive immune responses. The virus thereby employs theRetrovirology 2008, 5:79 http://www.retrovirology.com/content/5/1/79
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RNA silencing by HIVaINR antisense RNA Figure 3
RNA silencing by HIVaINR antisense RNA. MicroRNAs (miRNAs) and small interfering RNAs (siRNAs) could be proc-
essed from the HIVaINR antisense RNA[14] and duplex RNAs using the host cell protein components of the RNA interference 
(RNAi) and miRNA pathways. These small RNAs (siRNAs/miRNAs) are proposed to control gene expression in the human 
host cell in a sequence-specific manner by: (a) chromatin modification and silencing; (b) HIV-mediated RNAi leading to comple-
mentary target messenger RNA (mRNA) degradation; (c) miRNA targeted translational repression, and also cleavage if suffi-
cient complementary sequence. (d) Tat protein could function to eliminate or suppress RNA silencing and thereby allow intact 
mRNA for protein production. Discussed in text.Retrovirology 2008, 5:79 http://www.retrovirology.com/content/5/1/79
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host's own anti-viral RNA silencing defence against the
host cell. It can't be accidental that HAAmiRNA 1 has
sequence that could target multiple complementary sites
in human mRNA for the human IL-2R γ or common
gamma (γc) chain, a requisite component in the receptors
for all known T-cell growth factors (interleukins (IL)-2, IL-
4, IL-7, IL-9, IL-15, and IL-21). The same HAAmiRNA 1
sequence can also target multiple sites in the interleukin-
15 mRNA, a key cytokine involved in NK cell functioning.
In addition, until conditions are appropriate in the host
cell for intact HIV RNA and protein production, dicing up
the early transcripts (Figure 3b) or using miRNA/RISC for
translational repression (Figure 3c) would prevent host
innate and adaptive immune responses from obtaining
any sort of head start for recognition of viral proteins. The
presence of Tat protein, once the cell is activated, might
provide the signal that allows a preponderance of intact
viral mRNA to be made for more protein production and
production of virions (Figure 3d). It has been proposed
that the HIV-1 Tat protein also functions as a suppressor
of RNA silencing, by subverting the ability of Dicer to
process dsRNAs into siRNAs[84]. In plants, viruses have
evolved a variety of mechanisms to suppress RNA silenc-
ing [83,103,104]. However, Tat protein also binds directly
to the HIVaINR antisense RNA, and alters RNA stability
(LBL, unpublished observations). The mechanism for this
is unknown. A simple hypothesis would be that Tat pro-
tein, through its interaction with the HIVaINR antisense
RNA might alter the secondary/tertiary structure of the
HIVaINR antisense RNA, such that formation of the
required microRNA hairpin precursor(s) is altered and
functional microRNA does not result (diagrammed in Fig-
ure 3d). Experiments have shown that alteration of RNA
secondary structure by mutation can allow HIV-1 to
escape RNAi because of occlusion of an siRNA-target
sequence [105]. Alternatively, Tat could act at the level of
Dicer, as previously suggested[84], or through another
mechanism. Regardless, in order to produce the HIV anti-
sense proteins called HAPs, it was necessary to use a Tat-
producing cell line (Figure 3d)[14].
Implications for HIV-1 vaccine development
The particular HIV-1 genetic regions encompassing
HAAmiRNA sites 1–3 are well conserved in the B clade,
and even more remarkably, particularly conserve miRNA
sequence required for mRNA target recognition in most of
the clades of group M (A-D, F-H, J and K), with the excep-
tion of the O group strains (underlined, additional file
2)[106,107]. There is even conservation of a 7 nucleotide
"seed" of the HAAmiRNA1 in some of the chimpanzee
virus variants, CPZ.CAM 3 and 5 (additional file 2). The
HAAmiRNA site 1 and site 1* region overlaps and is com-
plementary to the predicted #4 microRNA precursor pre-
viously described by Bennasser, et al[30], and is bordered
by one of the most variable regions in the HIV-1 LTR
called the most frequent naturally-occurring length poly-
morphism (MFNLP) [106]. Conservation of a precursor
microRNA would be expected to be in balance with the
viral need to escape host RNA silencing mechanisms. The
endogenous siRNA produced by the virus, however,
mutates along with the viral template. This suggests that
selection pressure has maintained the microRNA sites as
essential for the virus. Even more interesting is that the
precursor microRNA 1 hairpin is entirely deleted/mutated
in a group of long-term survivors, who continued with T
cell function for longer than expected[108]. If, as sug-
gested in this paper, this particular site targets the human
IL-2RG (common gamma chain) mRNA and IL-15
mRNA, and can be shown to impact on T-cell and NK-cell
function, this must be taken into consideration when
designing vectors for gene therapy. Care must be taken to
remove these HAAmiRNA sites or alter their function, if
introducing the HIV-1 LTR into susceptible cells. Alterna-
tively, specifically targeting these sites with siRNAs that
eliminate their function without perpetuating any genetic
damage to the host might be considered.
Conclusion
RNA silencing for regulation of gene expression is now
recognized as an important tool for many species, includ-
ing humans, to control how and when proteins are made.
Viruses have undoubtedly already developed mechanisms
that allow them to survive in their host mammalian cell,
including subversion of the host cell machinery for RNA
silencing. HIV encodes, within its long terminal repeat, an
antisense gene responsible for RNA and protein prod-
ucts[14]. The antisense RNA transcribed from this gene
can generate an intrinsic, perfectly complementary RNA
that base-pairs to the beginning and end portion of the
genomic HIV RNA and mRNAs for the viral proteins. Dou-
ble-stranded RNA initiates RNAi and could allow intrinsic
HIV control of when viral RNAs are made. In addition, the
antisense RNA forms an intrinsic, intramolecular duplex
RNA consistent with microRNA precursor stem-loops.
Precursor microRNA stem-loops have already been pro-
posed for the sense HIV-1 RNA[17,18,29,30]. The individ-
ual human cellular mRNAs potentially targeted by a
single-stranded short RNA (miRNA) derived from this
HIV precursor RNA structure turn out to be mRNAs very
important in the human adaptive (and innate) immune
response. One of the (many) targets of the HIVaINR anti-
sense RNA miRNAs (HAAmiRNAs) is the human inter-
leukin-2 receptor gamma chain, also known as the
gamma common chain because it is a component of 6
separate cytokine receptors important in immune cell sig-
nalling and interactions. By this mechanism, I propose the
human immunodeficiency virus has found a way to crip-
ple effective host cell immune responses. In designing
HIV vaccines, this must be taken into account, becauseRetrovirology 2008, 5:79 http://www.retrovirology.com/content/5/1/79
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incorporation of this HIV antisense gene segment could
functionally impair, rather than build an effective
immune response. Alternatively, designing gene therapy
that targets this HAAmiRNA encoding gene segment,
before it gets to the CD4+ T cell, might change the balance
of power between virus and human host.
Competing interests
The author declares that they have no competing interests.
Authors' contributions




My gratitude to family and friends, who have been supportive (and listened 
to) this story for over a decade. My thanks also to Rachel Dvoretsky, who 
contributed artwork for Figures 2 and 3, and Louise Merkens, Ph.D., who 
contributed to M-fold analysis of the human IL-2RG (common gamma 
chain) mRNA.
References
1. Lee RC, Feinbaum RL, Ambros V: The C. elegans heterochronic
gene lin-4 encodes small RNAs with antisense complemen-
tarity to lin-14.  Cell 1993, 75:843-854.
2. Wightman B, Ha I, Ruvkun G: Posttranscriptional regulation of
the heterochronic gene lin-14 by lin-4 mediates temporal
pattern formation in C. elegans.  Cell 1993, 75:855-862.
3. Reinhart BJ, Slack FJ, Basson M, Bettinger JC, Pasquinelli AE, Rougvie
AE, Horvitz HR, Ruvkun G: The 21 nucleotide let-7 RNA regu-
lates developmental timing in Caenorhabditis elegans.
Nature 2000, 403:901-906.
4. Pasquinelli AE, Reinhart BJ, Slack F, Martindale MQ, Kuroda M, Maller
B, Srinivasan A, Fishman M, Hayward D, Ball E, et al.: Conservation
across animal phylogeny of the sequence and temporal reg-
ulation of the 21 nucleotide let-7 heterochronic regulatory
RNA.  Nature 2000, 408:86-89.
5. Olsen PH, Ambros V: The lin-4 regulatory RNA controls devel-
opmental timing in Caenorhabditis elegans by blocking LIN-
14 protein synthesis after the initiation of translation.  Dev Biol
1999, 216:671-680.
6. Lee RC, Ambros V: An extensive class of small RNAs in
Caenorhabditis elegans.  Science 2001, 294:862-864.
7. Bartel DP: MicroRNAs: Genomics, Biogenesis, Mechanism,
and Function.  Cell 2004, 116:281-297.
8. Kim VN: Small RNAs: Classification, biogenesis, and function.
Mol Cells 2005, 19:1-15.
9. Croce CM, Calin GA: miRNAs, cancer, and stem cell division.
Cell 2005, 122:6-7.
10. Scaria V, Jadhav V: microRNAs in viral oncogenesis.  Retrovirology
2007, 4:82.
11. Lum AM, Wang BB, Li L, Channa N, Bartha G, Wabl M: Retroviral
activation of the mir-146a microRNA cistron in T lym-
phoma.  Retrovirology 2007, 4:5.
12. Yeung ML, Benkirane M, Jeang K-T: Small non-coding RNAs,
mammalian cells, and viruses: regulatory interactions?  Retro-
virology 2007, 4:74.
13. Rosen CA, Sodroski JG, Haseltine WA: The location of cis-acting
regulatory sequences in the human T cell lymphotropic virus
type III (HTLV-III/LAV) long terminal repeat.  Cell 1985,
41:813-823.
14. Ludwig LB, Ambrus JL, Krawczyk K, Sharma S, Brooks S, Hsiao C-B,
Schwartz SA: Human Immunodeficiency Virus- Type 1 LTR
DNA contains an intrinsic gene producing antisense RNA
and protein products.  Retrovirology 2006, 3:80.
15. Kessler M, Mathews MB: Premature termination and process-
ing of human immunodeficiency virus type 1-promoted tran-
scripts.  J Virol 1992, 66(7):4488-4496.
16. Ratnasabapathy R, Sheldon M, Johal L, Hernandez N: The HIV-1
long terminal repeat contains an unusual element that
induces the synthesis of short RNAs from various mRNA and
snRNA promoters.  Genes Dev 1990, 12A:2061-2074.
17. Klase Z, Kale P, Winograd R, Gupta MV, Heydarian M, Berro R,
McCaffrey T, Kashanchi F: HIV-1 TAR element is processed by
Dicer to yield a viral micro-RNA involved in chromatin
remodeling of the viral LTR.  BMC Molecular Biology 2007, 8:63.
18. Ouellet DL, Plante I, Landry P, Barat C, Janelle M-E, Flamand L, Trem-
blay MJ, Provost P: Identification of functional microRNAs
released through asymmetrical processing of HIV-1 TAR
element.  Nucleic Acids Res 2008, 36:2353-2365.
19. Hammond SC, Bernstein E, Beach D, Hannon GJ: An RNA-directed
nuclease mediates posttranscriptional gene silencing in Dro-
sophila cells.  Nature 2000, 404:293-296.
20. Bernstein E, Caudy AA, Hammond SM, Hannon GJ: Role for a
bidentate ribonuclease in the initiation step of RNA interfer-
ence.  Nature 2001, 409:363-366.
21. Hutvagner G, McLachlan J, Pasquinelli AE, Balint E, Tuschl T, Zamore
PD:  A cellular function for the RNA-interference enzyme
Dicer in the maturation of the let-7 small temporal RNA.  Sci-
ence 2001, 293:834-838.
22. Meister G, Tuschl T: Mechanisms of gene silencing by double-
stranded RNA.  Nature 2004, 431:343-349.
23. Elbashir SM, Leneckel W, Tuschl T: RNA interference is medi-
ated by 21- and 22-nucleotide RNAs.  Genes Dev 2001,
15:188-200.
24. Elbashir SM, Martinez J, Patkaniowska A, Lendeckel W, Tuschl T:
Functional anatomy of siRNAs for mediating efficient RNAi
in Drosophila melanogaster embryo lysate.  EMBO J 2001,
20:6877-6888.
25. Okamoto K, Freundlich M: Mechanism for the autogenous con-
trol of the crp operon: transcriptional inhibition by a diver-
gent RNA transcript.  Proc Natl Acad Sci USA 1986, 83:5000-5004.
26. Green PJ, Pines O, Inouye M: The role of antisense RNA in gene
regulation.  Annu Rev Biochemistry 1986, 55:569-597.
27. Lau NC, Lim LP, Weinstein EG, Bartel DP: An abundant class of
tiny RNAs with probable regulatory roles in Caenorhabditis
elegans.  Science 2001, 294:858-862.
Additional file 1
HIVaINR antisense RNA [14] analyzed by Mfold [31-33].




HIVaINR antisense RNA [14] and predicted HAAmiRNAs at sites 1, 2 
and 3 (backward yellow arrows) are shown above the corresponding com-
plementary sequence in the HIV-1 sequence alignments for group M 
(strains A, B, C, D, F1, G, H, J and K), group N, and group O, as well 
as chimpanzee (CPZ) strains in the long terminal repeat (LTR), as 
obtained from the HIV Sequence Compendium 2000[107]. HAAmiRNA 
3 overlaps and is partially complementary to the nef microRNA:miR-
N367 described by Omoto, S., et al., [29] and HAAmiRNA 1 and pre-
cursor (pre-HAAmiRNA 1) overlaps and is complementary sequence to 
the predicted #4 microRNA precursor described by Bennasser, Y. et al 
[30]. Predicted seed regions for the microRNAs are shaded, and sequence 
targeting human mRNA is underlined. The B clade HXB2 is the reference 
sequence, with identical sequences in the strains below, unless otherwise 
indicated [107].
Click here for file
[http://www.biomedcentral.com/content/supplementary/1742-
4690-5-79-S2.pdf]Retrovirology 2008, 5:79 http://www.retrovirology.com/content/5/1/79
Page 12 of 13
(page number not for citation purposes)
28. Lagos-Quintana M, Rauhut R, Lendeckel W, Tuschl T: Identification
of novel genes coding for small expresssed RNAs.  Science
2001, 294:853-858.
29. Omoto S, Ito M, Tsutsumi Y, Ichikawa Y, Okuyama H, Andi BE, Sak-
sena NK, Fuji Y: HIV-1 nef suppression by virally encoded
microRNA.  Retrovirology 2004, 1:44.
30. Bennasser Y, Le SY, Yeung ML, Jeang KT: HIV-1 encoded candi-
date micro-RNAs and their cellular targets.  Retrovirology 2004,
1:43.
31. Zuker M: Mfold web server for nucleic acid folding and hybrid-
ization prediction.  Nucleic Aids Res 2003, 31:3406-3415.
32. Mathews DH, Sabina J, Zuker M, Turner DH: Expanded sequence
dependence of thermodynamic parameters improves pre-
diction of RNA secondary structure.  J Mol Biol 1999,
288:911-940.
33. Markham NR, Zuker M: DINAMelt web server for nucleic acid
melting prediction.  Nucleic Acids Res 2005, 33:W577-W581.
34. Lee Y, Ahn C, Han J, Choi H, Kim J, Yim J, Lee J, Provost P, Radmark
O, Kim S, Kim VN: The nuclear RNase III Drosha initiates
microRNA processing.  Nature 2003, 425:415-419.
35. Han J, Lee Y, Yeom KH, Kim YK, Jin H, Kim VN: The Drosha-
DGCR8 complex in primary microRNA processing.  Genes
Dev 2004, 18:3016-3027.
36. La n d th a l e r  M ,  Ya l c i n A ,  T us ch l T :  The human DiGeorge syn-
drome critical region gene 8 and its D. melanogaster
homolog are required for miRNA biogenesis.  Current Biology
2004, 14:2162-2167.
37. Han J, Lee Y, Yeom KH, Nam JW, Heo I, Rhee JK, Sogn SY, Cho Y,
Zhang BT, Kim VN: Molecular basis for the recognition of pri-
mary microRNAs by the Drosha-DGCR8 complex.  Cell 2006,
125:887-901.
38. Ritchie W, Legendre M, Gautheret D: RNA stem-loops: to be or
not to be cleaved by RNAse III.  RNA 2007, 13:457-462.
39. Filipowicz W, Jaskiewicz L, Kolb FA, Pillai RS: Post-transcriptional
gene silencing by siRNAs and miRNAs.  Current Opinion in Struct
Biol 2005, 15:331-341.
40. Zeng Y, Yi R, Cullen BR: Recognition and cleavage of primary
microRNA precursors by the nuclear processing enzyme
Drosha.  The EMBO Journal 2005, 24:138-148.
41. Zeng Y, Cullen BR: Efficient processing of primary microRNA
hairpins by Drosha requires flanking nonstructured RNA
sequences.  Journal of Biological Chemistry 2005, 280:27595-27603.
42. Hochsmann M, Toller T, Giegerich R, Kurtz S: Local similarity in
RNA secondary structures.  Proc IEEE Comput Soc Bioinform Conf
2003, 2:159-168.
43. Hochsmann M, Voss B, Giegerich R: Pure multiple RNA second-
ary structure alignments: a progressive profile approach.
IEEE/ACM Trans Comput Biol Bioinformatics 2004, 1:53-62.
44. Doench JG, Sharp PA: Specificity of microRNA target selection
in translational repression.  Genes Dev 2004, 18:504-511.
45. Lewis BP, Shih I, Jones-Rhoades MW, Bartel DP, Burge CB: Predic-
tion of mammalian microRNA targets.  Cell 2003, 115:787-798.
46. Lim LP, Lau NC, Garrett-Engele P, Grimson A, Schelter JM, Castle J,
Bartel DP, Linsley PS, Johnson JM: Microarray analysis shows that
some microRNAs downregulate large numbers of target
mRNAs.  Nature 2005, 433:769-773.
47. Doench JG, Peterson CP, Sharp PA: siRNAs can function as miR-
NAs.  Genes Dev 2003, 17:438-442.
48. John B, Enright AJ, Aravin A, Tuschl T, Sander C, Marks DS: Human
microRNA targets.  PLoS Biol 2004, 2:e363. (1862–1879).
49. Saxena S, Jonsson ZO, Dutta A: Small RNAs with imperfect
match to endogenous mRNA repress translation. Implica-
tions for off-target activity of small inhibitory RNA in mam-
malian cells.  J Biol Chem 2003, 278:44312-44319.
50. Kennedy MK, Glaccum M, Brown SN, Butz EA, Viney JL, Embers M,
Matsuki N, Charrier K, Sedger L, Willis CR, Brasel K, Morrissey PJ,
Stocking K, Schuh JC, Joyce S, Peschon JJ: Reversible defects in
natural killer and memory CD8 T cell lineages in interleukin-
15 deficient mice.  J Exp Med 2000, 191:771-780.
51. Gilmour KC, Fujii H, Cranston T, Davies EG, Kinnon C, Gaspar HB:
Defective expression of the interleukin-2/interleukin-15
receptor β subunit leads to a natural killer cell-deficient form
of severe combined immunodeficiency.  Blood 2001,
98:877-879.
52. Lodolce JP, Boone DL, Chai S, Swain RE, Dassopoulos T, Trettin S, Ma
A: IL-15 receptor maintains lymphoid homeostasis by sup-
porting lymphocyte homing and proliferation.  Immunity 1998,
9:669-676.
53. Strengell M, Sareneva T, Foster D, Julkunen I, Matikainen S: IL-21 up-
regulates the expression of genes associated with innate
immunity and Th1 response.  J Immunol 2002, 169:3600-3605.
54. Vosshenrich CA, Ranson T, Samson SI, Corcuff E, Colucci F, Rosma-
raki EE, DiSanto JP: Roles for common cytokine receptor
gamma-chain-dependent cytokines in the generation, differ-
entiation, and maturation of NK cell precursors and periph-
eral NK cells in vivo.  J Immunol 2005, 174:1213-1221.
55. vonFreeden-Jeffry U, Vierira P, Lucian A, McNeil T, Burdach SE, Mur-
ray R: Lymphopenia in interleukin (IL)-7 gene-deleted mice
identifies IL-7 as a nonredundant cytokine.  J Exp Med 1995,
181:1519.
56. Parrish-Novak J, Dillon SR, Nelson A, Hammond A, Sprecher C,
Gross JA, et al.: Interleukin 21 and its receptor are involved in
NK cell expansion and regulation of lymphocyte function.
Nature 2000, 408:57.
57. Russell SM, Keegan AD, Harada N, Nakamura Y, Noguchi M, Leland
P, Friedmann MC, et al.: Interleukin-2 receptor gamma chain: a
functional component of the interleukin-4 receptor.  Science
1993, 262:1880-1883.
58. Noguchi M, Nakamura Y, Russell SM, Ziegler SF, Tsang M, Cao X,
Leonard WJ: Interleukin-2 receptor gamma chain: a functional
component of the interleukin-7 receptor.  Science 1993,
262:1877-1880.
59. Giri JG, Ahdieh M, Eisenman J, Shanebeck K, Grabstein K, Kumaki S,
Namen A, et al.: Utilization of the beta and gamma chains of
the IL-2 receptor by the novel cytokine IL-15.  EMBO J 1994,
13:2822-2830.
60. Noguchi M, Yi H, Rosenblatt HM, Filipovitch AH, Adelstein S, Modi
WS, McBride OW, Leonard WJ: Interleukin-2 receptor gamma
chain mutation results in X-linked severe combined immun-
odeficiency in humans.  Cell 1993, 73:147-157.
61. Puck JM, Deschenes SM, Porter JC, Dutra AS, Brown CJ, Willard HF,
Henthorn PS: The interleukin-2 receptor gamma chain maps
to Xq13.1 and is mutated in X-linked severe combined
immunodeficiency, SCIDX1.  Hum Mol Genet 1993, 2:1099-1104.
62. Pepper AE, Buckley RH, Small TN, Puck JM: Two mutational
hotspots in the interleukin-2 receptor gamma chain gene
causing human X-linked severe combined immunodefi-
ciency.  Am J Hum Genet 1995, 57:564-571.
63. Burchill MA, Yang J, Vang KB, Farrar MA: Interleukin-2 receptor
signaling in regulatory T cell development and homeostasis.
Immunol Lett 2007, 114:1-8.
64. Olosz F, Malek TR: Structural basis for binding multiple ligands
by the common cytokine receptor gamma chain.  J of Biol
Chem 2002, 277:12047-12052.
65. O'Shea JJ: Jaks, STATS, cytokine signal transduction, and
immunoregulation: are we there yet?  Immunity 1997, 7:1-11.
66. Russell SM, Johnston JA, Noguchi M, Kawamura M, Bacon CM, Fried-
mann M, Berg M, et al.: Interaction of IL-2R beta and gamma c
chains with Jak1 and Jak3: implications for XSCID and XCID.
Science 1994, 266:1042-1045.
67. Abbas AK, Lichtman AH: Cellular and Molecular Immunology 2003.
68. Goldman AS, Palkowetz KH, Rudloff HE, Dallas DV, Schmalstieg FC:
Genesis of progressive T-cell deficiency owing to a single
missense mutation in the common gamma chain gene.  Scand
J Immunol 2001, 54:582-591.
69. Antar LN, Bassell GJ: Sunrise at the synapse: the FMRP mRNP
shaping the synaptic interface.  Neuron 2003, 37:555-558.
70. Brown V, Jin P, Ceman S, Darnell JC, O'Donnell WT, et al.: Microar-
ray identification of FMRP-associated brain mRNAs and
altered mRNA translational profiles in fragile × syndrome.
Cell 2001, 107:477-487.
71. Chen L, Yun SW, Seto J, Liu W, Toth M: The fragile × mental
retardation protein binds and regulates a novel class of
mRNAs containing U rich target sequences.  Neuroscience
2003, 120:1005-1017.
72. Miyashiro KY, Beckel-Mitchener A, Purk TP, Becker KG, Barret T, et
al.: RNA cargoes associating with FMRP reveal deficits in cel-
lular functioning in Fmr1 null mice.  Neuron 2003, 37:417-431.
73. Jin P, Zarnescu DC, Ceman S, Nakamoto M, Mowrey J, Jongens TA,
Nelson DL, Moses K, Warren ST: Biochemical and genetic inter-
action between the fragile × mental retardation protein and
the microRNA pathway.  Nat Neurosci 2004, 7:113-117.Publish with BioMed Central    and   every 
scientist can read your work free of charge
"BioMed Central will be the most significant development for 
disseminating the results of biomedical research in our lifetime."
Sir Paul Nurse, Cancer Research UK
Your research papers will be:
available free of charge to the entire biomedical community
peer reviewed and published  immediately upon acceptance
cited in PubMed and archived on PubMed Central 
yours — you keep the copyright
Submit your manuscript here:
http://www.biomedcentral.com/info/publishing_adv.asp
BioMedcentral
Retrovirology 2008, 5:79 http://www.retrovirology.com/content/5/1/79
Page 13 of 13
(page number not for citation purposes)
74. Caudy AA, Myers M, Hannon GJ, Hammond SM: Fragile X-related
protein and VIG associate with the RNA interference
machinery.  Genes Dev 2002, 16:2491-1496.
75. Ishizuka A, Siomi MC, Siomi H: A Drosophila fragile × protein
interacts with components of RNAi and ribosomal proteins.
Genes Dev 2002, 16:2497-2508.
76. Triboulet R, Mari B, Lin Y-L, Chable-Bessia C, Bennasser Y, Lebrigand
K, Cardinaud B, Maurin T, Barbry P, Baillat V, Reynes J, Corbeau P,
Jeang K-T, Benkirane M: Suppression of microRNA-silencing
pathway by HIV-1 during virus replication.  Science 2007,
315:1579-1582.
77. Taganov KD, Boldin MP, Chang K-J, Baltimore D: NF-kB-depend-
ent induction of microRNA miR-146, an inhibitor targeted to
signaling proteins of innate immune responses.  Proc Natl Acad
Sci USA 2006, 103:12481-12486.
78. Lai EC: miRNAs: whys and wherefores of miRNA-mediated
regulation.  Current Biology 2005, 15:R458-R460.
79. Nable G, Baltimore D: An inducible transcription factor acti-
vates expression of human immunodeficiency virus in T
cells.  Nature 1987, 326:711-713.
80. Waterhouse PM, Graham MW, Wang MB: Virus resistance and
gene silencing in plants can be induced by simultaneous
expression of sense and antisense RNA.  Proc Natl Acad Sci USA
1998, 95:13959-13964.
81. Waterhouse PM, Wang MB, Lough T: Gene silencing as an adap-
tive defence against viruses.  Nature 2001, 411:838-842.
82. Mourrain P, Beclin C, Elmayan T, Feuerbach F, Godon C, Morel JB,
Jouette D, Lacombe AM, Nikic S, Picault N, Remoue K, Sanial M, Vo
TA, Vaucheret H: Arabidopsis SGS2 and SGS3 genes are
required for posttranscriptional gene silencing and and nat-
ural virus resistance.  Cell 2000, 101:533-542.
83. Voinnet O: RNA silencing as a plant immune system against
viruses.  Trends in Genetics 2001, 17:449-459.
84. Bennasser Y, Le SY, Benkirane M, Jeang KT: Evidence that HIV-1
encodes an siRNA and a suppressor of RNA silencing.  Immu-
nity 2005, 22:607-619.
85. Martinez J, Patkaniowska A, Urlaub H, Luhrmann R, Tuschl T: Single-
stranded antisense siRNAs guide target RNA cleavage in
RNAi.  Cell 2002, 110:563-574.
86. Lee Y, Jeon K, Lee JT, Kim S, Kim VN: MicroRNA maturation:
stepwise processing and subcellular localization.  EMBO J 2002,
21:4663-4670.
87. Basyuk E, Suavet F, Doglio A, Bordonne R, Bertrand E: Human let-
7 stem-loop precursors harbor features of RNase III cleavage
products.  Nucleic Acids Research 2003, 31:6593-6597.
88. Yi R, Qin Y, Macara IG, Cullen BR: Exportin-5 mediates the
nuclear export of pre-microRNAs and short hairpin RNAs.
Genes Dev 2003, 17:3011-3016.
89. Lund E, Guttinger S, Calado A, Dahlberg JE, Kutay U: Nuclear
export of microRNA precursors.  Science 2004, 303:95-98.
90. Zeng Y, Cullen BR: Structural requirements for pre-microRNA
binding and nuclear export by Exportin 5.  Nucleic Acids Res
2004, 32:4776-4785.
91. Carmell MA, Xuan Z, Zhang MQ, Hannon GJ: The Argonaute fam-
ily: tentacles that reach into RNAi, developmental control,
stem cell maintenance, and tumorigenesis.  Genes Dev 2002,
16:2733-2742.
92. Zhang H, Kolb FA, Jaskiewicz L, Westhof E, Filipowicz W: Single
processing center models for human Dicer and bacterial
RNase III.  Cell 2004, 118:57-68.
93. Carmell MA, Hannon GJ: RNase III enzymes and the initiation
of gene silencing.  Nat Struct Mol Biol 2004, 11:214-218.
94. Gatignol A, Buckler-White A, Berkhout B, Jeang KT: Characteriza-
tion of a human TAR RNA-binding protein that activates the
HIV-1 LTR.  Science 1991, 251:1597-1600.
95. Haase AD, Jaskiewicz L, Zhang H, Laine S, Sack R, Gatignol A, Filipo-
wicz W: TRBP, a regulator of cellular PKR and HIV-1 virus
expression, interacts with Dicer and functions in RNA silenc-
ing.  EMBO J 2005, 6:961-967.
96. Chendrimada TP, Gregory RI, Kumaraswamy E, Norman J, Cooch N,
Nishikura K, Shiekhattar R: TRBP recruits the Dicer complex to
Ago2 for microRNA processing and gene silencing.  Nature
2005, 436:740-744.
97. Mourelatos Z, Dostie J, Paushkin S, Sharma A, Charroux B, Abel L,
Rappsilber J, Mann M, Dreyfuss G: miRNPs: a novel class of ribo-
nucleoproteins containing numerous microRNAs.  Genes Dev
2002, 16:720-728.
98. Doi N, Zenno S, Ueda R, Ohki-Hamazaki H, Ui-Tei K, Saigo K: Short-
interfering-RNA-mediated gene silencing in mammalian
cells requires Dicer and eIF2C translation initiation factors.
Current Biology 2003, 13:41-46.
99. Liu J, Carmell MA, Rivas FV, Marsden CG, Thomson JM, Song JJ, Ham-
mond SM, Joshua-Tor L, Hannon GJ: Argonaute2 is the catalytic
engine of mammalian RNAi.  Science 2004, 305:1437-1441.
100. Meister G, Landthaler M, Patkaniowska A, Dorsett Y, Teng G, Tuschl
T: Human Argonaute2 mediates RNA cleavage targeted by
miRNAs and siRNAs.  Mol Cell 2004, 15:185-197.
101. Rivas FV, Tolia NH, Song JJ, Aragon JP, Liu J, Hannon GJ, Joshua-Tor
L:  Purified Argonaute 2 and an siRNA form recombinant
human RISC.  Nat Struct Mol Biol 2005, 12:340-349.
102. Caudy AA, Ketting RF, Hammond SM, Denli AM, Bathoorn AM, Tops
BB, Silva JM, Myers MM, Hannon GJ, Plasterk RH: A micrococcal
nuclease homologue in RNAi effector complexes.  Nature
2003, 425:411-414.
103. Ye K, Malinina L, Patel DJ: Recognition of small interfering RNA
by a viral suppressor of RNA silencing.  Nature 2003,
426:874-878.
104. Roth BM, Pruss GJ, Vance VB: Plant viral suppressors of RNA
silencing.  Virus Research 2004, 102:97-108.
105. Westerhout EM, Ooms M, Vink M, Das AT, Berkhout B: HIV-1 can
escape from RNA interference by evolving an alternative
structure in its RNA genome.  Nucleic Acids Res 2005, 33:796-804.
106. Kuiken C, Foley B, Hahn B, Marx P, McCutchan F, Mellors J, Wolinsky
S, Korber B: HIV Sequence Compendium 2001.  2001.
107. Kuiken C, Foley B, Hahn B, Marx P, McCutchan F, Mellors J, Mullins J,
Wolinsky S, Korber B: HIV Sequence Compendium 2000.  2000.
108. Deacon NJ, Tsykin A, Solomon A, Smith K, Ludford-Menting M,
Hooker DJ, McPhee DA, Greenway AL, Ellett A, Chatfield C, et al.:
Genomic structure of an attenuated quasi species of HIV-1
from blood transfusion donor and recipients.  Science 1995,
270:988-991.